Barinthus Biotherapeutics Plc ADR
(BRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,463 | -15,520 | -73,447 | -56,157 | -42,047 |
| Depreciation Amortization | 2,897 | 1,430 | 5,429 | 3,994 | 2,520 |
| Income taxes - deferred | -44 | -37 | -3,075 | -2,254 | -1,652 |
| Accounts receivable | N/A | N/A | 5,800 | N/A | 5,606 |
| Accounts payable and accrued liabilities | 967 | -524 | -3,378 | 417 | -1,916 |
| Other Working Capital | 2,741 | 1,285 | 6,171 | 17,053 | 8,796 |
| Other Operating Activity | 2,074 | 1,544 | 11,575 | 5,625 | 8,562 |
| Operating Cash Flow | $-23,828 | $-11,822 | $-50,925 | $-31,322 | $-20,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -500 | -308 | -5,413 | -5,566 | -5,530 |
| Investing Cash Flow | $-500 | $-308 | $-5,413 | $-5,566 | $-5,530 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 861 | 503 | 2,035 | 1,926 | 1,880 |
| Other Financing Activity | 0 | 0 | -163 | -163 | -163 |
| Financing Cash Flow | $861 | $503 | $1,872 | $1,763 | $1,717 |
| Exchange Rate Effect | -849 | -492 | 2,171 | 1,049 | 2,589 |
| Beginning Cash Position | 142,090 | 142,090 | 194,385 | 194,385 | 194,385 |
| End Cash Position | 117,774 | 129,971 | 142,090 | 160,309 | 173,030 |
| Net Cash Flow | $-24,316 | $-12,119 | $-52,295 | $-34,076 | $-21,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,828 | -11,822 | -50,925 | -31,322 | -20,131 |
| Capital Expenditure | -500 | -308 | -5,413 | -5,566 | -5,530 |
| Free Cash Flow | -24,328 | -12,130 | -56,338 | -36,888 | -25,661 |